EC

Euclidean Capital LLC

13F
Euclidean Capital LLC
Last update 2024-08-14 11 Stocks (0 new)
Value $796.00 Mil Turnover 12 %
Countries:
Top Holdings: SPY(78.43%)INDA(17.00%)FHTX(1.14%)ORIC(0.88%)ALEC(0.75%)
Portfolio Report
Summary Stock Picks Current Portfolio
Euclidean Capital LLC Top Holdings of 2024-06-30 View Full List
Ticker
Company
Shares
Value ($1000)
Shares Change %
Weighting %
Trade Impact %
% of Shares outstanding
3M Change %
YTD Change %
Market Cap $Mil
Industry
SPY 		S&P 500 ETF TRUST ETF
1,146,979
624208.910
+17.68%
78.430
+11.78%
-
+11.47%
+21.33%
596470.496
 
INDA 		iShares MSCI India ETF
2,425,144
135274.530
0%
17.000
0%
-
-0.20%
+12.17%
10646.607
 
FHTX 		Foghorn Therapeutics Inc
1,573,761
9049.130
0%
1.140
0%
2.840
+59.93%
+38.60%
494.638
Biotechnology
ORIC 		ORIC Pharmaceuticals Inc
989,410
6995.130
0%
0.880
0%
1.400
+9.13%
+5.22%
682.851
Biotechnology
ALEC 		Alector Inc
1,307,858
5937.680
0%
0.750
0%
1.340
-1.28%
-37.41%
486.119
Biotechnology
PMVP 		PMV Pharmaceuticals Inc
2,627,643
4256.780
0%
0.530
0%
5.100
+13.01%
-46.77%
85.008
Biotechnology
ME 		23andMe Holding Co
512,156
4007.110
0%
0.500
0%
2.020
-34.95%
-74.00%
122.725
Medical Diagnostics & Research
TNYA 		Tenaya Therapeutics Inc
1,015,705
3148.690
0%
0.400
0%
1.290
-16.47%
-34.26%
168.034
Biotechnology
RAPT 		RAPT Therapeutics Inc
657,899
2006.590
0%
0.250
0%
1.890
-9.59%
-90.14%
85.514
Biotechnology
SRZN 		Surrozen Inc
87,696
960.270
0%
0.120
0%
2.740
+49.04%
+16.38%
35.072
Biotechnology

Euclidean Capital LLC's Historical Top Holdings Breakdowns

Euclidean Capital LLC's Top Stock Picks View Full List
Ticker
Company
Date
Action
Impact %
Price Range
Price
Price Change from Avrg%
Comment
Current Shares
Share Change
SPY 		S&P 500 ETF TRUST ETF2024-06-30Add
+11.78%
â—Ź
495.16 ($523.39) 548.49
$576.65
10.18%
Add 17.68%
1,146,979
172,338
GLD 		SPDR Gold Shares ETF2024-06-30Sold Out
-11.40%
â—Ź
207.82 ($216.29) 224.56
$253.36
17.14%
Sold Out
0
-432,271
NGM NGM Biopharmaceuticals Inc2024-06-30Sold Out
-0.20%
â—Ź
1.54 ($1.55) 1.56
$1.54
-0.65%
Sold Out
0
-992,168
GLD 		SPDR Gold Shares ETF2024-03-31Reduce
-20.61%
â—Ź
184.42 ($191.93) 205.72
$253.36
32.01%
Reduce -68.9%
432,271
-957,729
SPY 		S&P 500 ETF TRUST ETF2024-03-31Add
+3.86%
â—Ź
467.28 ($497.86) 523.17
$576.65
15.83%
Add 6.27%
974,641
57,500
SPY 		S&P 500 ETF TRUST ETF2023-12-31Add
+22.72%
â—Ź
410.68 ($445.46) 476.69
$576.65
29.45%
Add 86.22%
917,141
424,641
GLD 		SPDR Gold Shares ETF2023-12-31Reduce
-13.75%
â—Ź
168.83 ($183.27) 192.59
$253.36
38.24%
Reduce -34.59%
1,390,000
-735,000
INDA 		iShares MSCI India ETF2023-12-31Reduce
-11.70%
â—Ź
42.73 ($45.49) 49.02
$54.75
20.36%
Reduce -50%
2,425,144
-2,425,144
PMVP 		PMV Pharmaceuticals Inc2023-12-31Reduce
-1.76%
â—Ź
1.23 ($2.65) 6.6
$1.65
-37.74%
Reduce -50%
2,627,643
-2,627,643
RAPT 		RAPT Therapeutics Inc2023-12-31Reduce
-1.20%
â—Ź
11.28 ($15.47) 25.46
$2.45
-84.16%
Reduce -50%
657,899
-657,899

Euclidean Capital LLC Total Holding History ($B)

To

Euclidean Capital LLC's Asset Allocation

To

Euclidean Capital LLC Past Portfolios

Portfolio Date Number of Stocks New Stocks Total Value ($Mil) Q/Q Turnover

Top Ranked Articles

  • 1

Euclidean Capital LLC's Hypothetical Growth since 2024-06-30

Euclidean Capital LLC's Yearly Returns

Year Portfolio % % Excess Gain %

Euclidean Capital LLC's Holdings Heat Map

Size field:

Euclidean Capital LLC's Holdings Bubble Chart

Euclidean Capital LLC News

  • 1

Discussions on Euclidean Capital LLC

No discussions yet.
Research Tools
All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board
Product
Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文
Education
Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation
Company
About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program
Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey
Follow Us
download GuruFocus on Apple store download GuruFocus on Google Play
Disclaimers
GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.
© 2004-2024 GuruFocus.com, LLC. All Rights Reserved.